In today’s digital age, progress in medical science is changing how diseases are diagnosed and treated. Between these innovations, if there is a name that has recently attracted a lot of attention in the medical field, then it is an accurate drug.

At its core, the presipion medicine stands as a revolutionary approach that treats tailor people based on their genes. But can it help to change how we treat diseases, especially cancer?

In a special interview with Today India, Dr. Shitij Kapoor, Vice Chancellor and President of King’s College London, talked about accurate medicine and its applications.

What exactly is the exact drug?

“For a very long time, we are always making a diagnosis and offering a treatment that was just the medicine as usual,” Dr. Shitiz Kapoor says.

Traditional therapy depends on a comprehensive approach where patients with the same disease receive similar treatment. However, the princely medicine allows doctors to identify the subtypes of diseases, accordingly stitching treatment.

“Diagnosis like breast cancer breaks down in small institutions. When you do genetics, you realize that, let’s say, four types of breast cancer,” they say.

By identifying these genetic differences, doctors can prescribe targeted treatments that patients improve results.

How can it help with cancer?

Principal Medicine has made significant progress in oncology. Cancer, once classified as the same disease, is now understood that there are many variations based on genetic mutation. This understanding allows doctors to select treatments that specifically target these mutations.

“At one level, someone has breast cancer, but then when you section and when you do genetics, you realize that there are there, assume, 4 types of breast cancer. They look the same, the symptoms may be the same, but you find that either the person’s genetics or cancer’s genetics are different, and then treatment is targeted on the basis of it, ”Dr. Says Kapoor.

Can you tolerate it?

Even though the accurate drug leads to better results, strength is a matter of concern. “The latest new drug has come for a brain disease called metacromatic leukodistrophy. A single treatment [through precision medicine] US $ 4.5 million for a person spends for a person. No person can bear it even in the United States where it is being introduced; It is only introduced in the context of insurance, “Dr. Kapoor says.

Economic models of accurate therapy, where treatment applies to small patient groups, means that drug prices are high. Despite this, experts like him are hoping that as technology progresses, the cost-efficiency of these treatments will improve.

How can AI help here?

Unlike other areas such as travel, fashion, food, and more, here too, artificial intelligence, too, future healthcare is playing an important role in increasing the precise medicine by improving healthcare. AI analyzes giant datasets, identifying patterns in genetic and lifestyle factors that can predict the risks of the disease.

“If I just ask someone about the family history of diabetes, I can predict their risk. Now, AI enhances it by analyzing the detailed genetic and lifestyle data,” Dr. Kapoor says.

However, in addition to its steep pricing, the precise drug is not yet widely available to Indians, such as high blood pressure and diabetes drugs.

“Hope is that this principle of using your genetics to guide your treatment in a large clinical category like blood pressure or heart disease will lead to better treatment, and we hope they will keep coming,” Dr. . Kapoor has a conclusion.